$BRQL
brooqLy, Inc.

2023 Q2 Form 10-K Financial Statement

#000147793223002644 Filed on April 17, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q4 2022
Revenue $1.00 $993.00
YoY Change -99.85% -67.34%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $34.65K $312.3K
YoY Change 81.18%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.480K $19.48K
YoY Change 1929.17%
% of Gross Profit
Operating Expenses $34.65K $312.3K
YoY Change -30.12% 81.18%
Operating Profit -$34.65K -$311.3K
YoY Change -29.18%
Interest Expense $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $0.00 $100.00
YoY Change
Pretax Income -$34.65K -$311.2K
YoY Change -29.18% 7.55%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$34.65K -$311.2K
YoY Change -29.18% 7.55%
Net Earnings / Revenue -3465100.0% -31335.35%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 23.58M shares 22.31M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.430K $0.00
YoY Change -100.0%
Cash & Equivalents $6.426K $1.00
Short-Term Investments
Other Short-Term Assets $30.20K $200.00
YoY Change 0.0%
Inventory
Prepaid Expenses $30.20K $204.00
Receivables
Other Receivables
Total Short-Term Assets $36.63K $205.00 $210.00
YoY Change -99.32% -99.31%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $129.5K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $114.6K $129.5K $129.5K
YoY Change 162.87% 162.85%
TOTAL ASSETS
Total Short-Term Assets $36.63K $205.00 $210.00
Total Long-Term Assets $114.6K $129.5K $129.5K
Total Assets $151.2K $129.7K $129.7K
YoY Change 63.14% 63.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $53.61K $118.5K $118.5K
YoY Change 630.6% 630.78%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $55.00K $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $131.4K $140.4K $140.4K
YoY Change 543.55% 543.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $131.4K $140.4K $140.4K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $131.4K $140.4K
YoY Change 543.6%
SHAREHOLDERS EQUITY
Retained Earnings -$650.0K -$480.5K
YoY Change 60.5% 66.07%
Common Stock $2.364K $2.259K
YoY Change 0.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.84K -$10.67K -$10.67K
YoY Change
Total Liabilities & Shareholders Equity $151.2K $129.7K $129.7K
YoY Change 96.67% 63.14% 63.13%

Cashflow Statement

Concept 2023 Q2 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$34.65K -$311.2K
YoY Change -29.18% 7.55%
Depreciation, Depletion And Amortization $7.480K $19.48K
YoY Change 1929.17%
Cash From Operating Activities -$102.5K -$28.33K
YoY Change -72.46%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $99.71K
YoY Change 98.55%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$99.71K
YoY Change 98.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $78.00K
YoY Change -70.62%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 75.00K $98.00K
YoY Change -46.48%
NET CHANGE
Cash From Operating Activities -102.5K -$28.33K
Cash From Investing Activities 0.000 -$99.71K
Cash From Financing Activities 75.00K $98.00K
Net Change In Cash -27.55K -$30.03K
YoY Change -200.01%
FREE CASH FLOW
Cash From Operating Activities -$102.5K -$28.33K
Capital Expenditures $0.00 $99.71K
Free Cash Flow -$102.5K -$128.0K
YoY Change -16.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001854526
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q4 dei Entity Public Float
EntityPublicFloat
0 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22584982 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22417500 shares
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-56399
CY2022 dei Entity Registrant Name
EntityRegistrantName
BrooqLy, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2265420
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
10101 S. Robert Road
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 209
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Palos Hills
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60465
CY2022 dei City Area Code
CityAreaCode
224
CY2022 dei Local Phone Number
LocalPhoneNumber
789-6673
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23584982 shares
CY2022 dei Auditor Firm
AuditorFirmId
587
CY2022 dei Auditor Name
AuditorName
RBSM LLP
CY2022 dei Auditor Location
AuditorLocation
New York, NY
CY2022Q4 us-gaap Cash
Cash
1 usd
CY2021Q4 us-gaap Cash
Cash
30035 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
204 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
204 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
205 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
30239 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
129488 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
49260 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
129488 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
49260 usd
CY2022Q4 us-gaap Assets
Assets
129693 usd
CY2021Q4 us-gaap Assets
Assets
79499 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
118459 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
20736 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
21906 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1075 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
140365 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21811 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22584982 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22417500 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2259 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2242 usd
CY2022Q4 brooqly Common Stock To Be Issued
CommonStockToBeIssued
20000 usd
CY2021Q4 brooqly Common Stock To Be Issued
CommonStockToBeIssued
29497 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
447538 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
283258 usd
CY2022Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
0 usd
CY2021Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
88000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-480469 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-169309 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-10672 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
57688 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
129693 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79499 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
993 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3039 usd
CY2022 us-gaap Revenues
Revenues
993 usd
us-gaap Revenues
Revenues
3039 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
120810 usd
us-gaap Professional Fees
ProfessionalFees
64871 usd
CY2022 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
191446 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
107477 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
312256 usd
us-gaap Operating Expenses
OperatingExpenses
172348 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-311263 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-169309 usd
CY2022 us-gaap Other Income
OtherIncome
103 usd
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
103 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-311160 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-169309 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-311160 usd
us-gaap Net Income Loss
NetIncomeLoss
-169309 usd
CY2022 brooqly Net Loss Per Common Stock Basic And Fully Diluted1
NetLossPerCommonStockBasicAndFullyDiluted1
-0.01
brooqly Net Loss Per Common Stock Basic And Fully Diluted1
NetLossPerCommonStockBasicAndFullyDiluted1
-0.01
CY2022 brooqly Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
22336023 shares
brooqly Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
15747815 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-311160 usd
us-gaap Net Income Loss
NetIncomeLoss
-169309 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
19480 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
956 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
144800 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
49496 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
97722 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
20736 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
204 usd
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
20831 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
1076 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28327 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-97248 usd
CY2022 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
99707 usd
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
50217 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-99707 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-50217 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
78000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
177500 usd
CY2022 brooqly Shares To Be Issued For Cash
SharesToBeIssuedForCash
20000 usd
brooqly Shares To Be Issued For Cash
SharesToBeIssuedForCash
0 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
98000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
177500 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-30034 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
30035 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30035 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30035 usd
CY2022 brooqly Reversal Of Warrant Stocks
ReversalOfWarrantStocks
100000 usd
brooqly Reversal Of Warrant Stocks
ReversalOfWarrantStocks
0 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
57688 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
78000 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
144800 usd
CY2022 brooqly Shares To Be Issued
SharesToBeIssued
20000 usd
CY2022 brooqly Reversal Of Warrants Amount
ReversalOfWarrantsAmount
0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-311160 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-10672 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
0 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
177500 usd
brooqly Shares To Be Issued
SharesToBeIssued
29497 usd
brooqly Subscription Receivable Amount
SubscriptionReceivableAmount
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-169309 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
57688 usd
CY2022 brooqly Description Of Correction Of Immaterial Misstatement
DescriptionOfCorrectionOfImmaterialMisstatement
Company became aware of an adjustment to correct an error in its previously issued financial statements regarding additional paid in capital and interest expense in the amount of $120,000
CY2022 brooqly Additional Paid In Capital And Interest Expense
AdditionalPaidInCapitalAndInterestExpense
120000 usd
CY2021 brooqly Additional Paid In Capital And Interest Expense
AdditionalPaidInCapitalAndInterestExpense
120000 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22584982 shares
CY2021 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
21437500 shares
CY2021 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
177500 usd
CY2021Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
88000 usd
CY2021 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
100000 shares
CY2021 brooqly Shares Issued For Services Amount
SharesIssuedForServicesAmount
20000 usd
CY2022 brooqly Cancellation Of Shares
CancellationOfShares
1000000 shares
CY2022Q1 brooqly Purchase Of Shares During Period
PurchaseOfSharesDuringPeriod
1000000 shares
CY2022Q1 brooqly Purchase Of Warrants During Period
PurchaseOfWarrantsDuringPeriod
1000000 shares
CY2022Q1 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
0.10
CY2022Q1 brooqly Desription Of Investment1
DesriptionOfInvestment1
The investment was in excess of $50,000 entitling the investor to receive shares and warrants at a reduced price instead of at $0.20 per share from those investors investing less than $50,000. The investor failed to pay $75,000 of the aggregate investment and the Company has determined that the investor will not receive the benefit of the $0.10 per share price and its shares shall be calculated on the basis of $0.20 per share, for which there is an adjusted number of common shares (and no warrants), of 125,000 shares for the cash proceeds of $25,000 that the company received from the investor
CY2022 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
550000 shares
CY2022 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
78000 usd
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
350000 shares
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
35000 usd
CY2022 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
20000 usd
CY2022 brooqly Shares To Be Issued Shares
SharesToBeIssuedShares
100000 shares
CY2022 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
617482 shares
CY2022 brooqly Shares Issued For Services Amount
SharesIssuedForServicesAmount
174295 usd

Files In Submission

Name View Source Status
0001477932-23-002644-index-headers.html Edgar Link pending
0001477932-23-002644-index.html Edgar Link pending
0001477932-23-002644.txt Edgar Link pending
0001477932-23-002644-xbrl.zip Edgar Link pending
brooqly-20221231.xsd Edgar Link pending
brooqly_10k.htm Edgar Link pending
brooqly_ex311.htm Edgar Link pending
brooqly_ex312.htm Edgar Link pending
brooqly_ex321.htm Edgar Link pending
brooqly_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
brooqly-20221231_lab.xml Edgar Link unprocessable
brooqly-20221231_def.xml Edgar Link unprocessable
brooqly-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
brooqly_10k_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
brooqly-20221231_cal.xml Edgar Link unprocessable